论文部分内容阅读
目的观察氯诺昔康联合屈他维林对急诊肾绞痛患者治疗的疗效与安全性。方法将84例急诊肾绞痛患者随机分为治疗组和对照组,各42例,治疗组给予肌内注射氯诺昔康8mg,随后予屈他维林80mg,静脉推注,对照组给予肌内注射布桂嗪100mg,后予山莨胆碱10mg静脉注射,分别观察两组用药后30～60min的镇痛效果及不良反应。结果治疗组、对照组总有效率分别为90.5%和76.2%,不良反应率分别为23.8%和81.0%,组间差别均有统计学意义(P<0.05)。结论氯诺昔康联合屈他维林对肾绞痛疗效好,不良反应少,适合急诊肾绞痛患者的治疗。
Objective To observe the efficacy and safety of lornoxicam in combination with drotaverine in the treatment of patients with emergency renal colic. Methods Eighty-four patients with acute renal colic were randomly divided into treatment group and control group, 42 cases in each group. The treatment group was given intramuscular injection of lornoxicam 8 mg, followed by intravenous injection of Quetalverin 80 mg and the control group with muscle Bupivolin 100mg intra-injection, followed by 10mg of oxymatrine intravenous injection were observed 30min 60min after the two groups analgesic effect and adverse reactions. Results The total effective rates of the treatment group and the control group were 90.5% and 76.2% respectively, and the adverse reaction rates were 23.8% and 81.0% respectively. The difference between the two groups was statistically significant (P <0.05). Conclusion Lornoxicam combined with drotaverine has a good effect on renal colic and has few adverse reactions. It is suitable for the treatment of emergency renal colic.